The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as pharmaceutical compositions containing the same and methods of use thereof related to the treatment of cancer and other diseases.

 
Web www.patentalert.com

< HISTONE DEACETYLASE INHIBITORS SENSITIZE CANCER CELLS TO EPIDERMAL GROWTH FACTOR INHIBITORS

> CHROMANE AND CHROMENE DERIVATIVES AND USES THEREOF
~ 00452